Report
Adam Karlsson ...
  • Erik Cassel
  • Gonzalo Castanon

Probi - Weak Q3, but hope for 2023

Q3 result in line with pre-announced numbers US weaker in Q3; expect resumed group growth in 2023 Share trading at NTM EV/EBITA of 14x
Underlying
Probi AB

Probi is engaged in the development and manufacture of health products. Co. offers probiotics to food, health and pharmaceutical companies. Co. operates in two business areas: Functional Food and Consumer Healthcare. The Functional Food segment develops food that provides beneficial health effects, under such brands as ProViva, GoodBelly and Golden Circle Healthy Life, or tablets and capsules under brands Bion Transit and Nature Made. The Consumer Healthcare segment develops, markets and sells Co. probiotics with pharmaceutical companies, under Co.'s proprietary brand and those of its partners. Co. also offers its proprietary brands, Probi Mage® and Probi Frisk®, in the Nordic market.

Provider
ABG Sundal Collier Sponsored
ABG Sundal Collier Sponsored

ABG Sundal Collier is the independent, Nordic investment banking powerhouse, developed over 30 years, founded on a hard working partnership culture and the ability to attract top talent.

Our strategy is to be an advisor and an intermediary, and the core product offering comprise corporate advisory services, corporate financing services and investor research and brokerage services.

Our corporate advisory team offers access to a broad financial and industrial network and unparalleled transaction experience. We provide financing to corporates through our superior Nordic and international distribution platform, and we are optimally structured for naturally matching trading flows, delivering best execution for clients.

The group employ approx. 250 staff working from the Nordic offices in Norway, Sweden and Denmark and in the offices in the key international markets US, UK and Germany. 


Analysts
Adam Karlsson

Erik Cassel

Gonzalo Castanon

ResearchPool Subscriptions

Get the most out of your insights

Get in touch